Clinical Trial Update: The Role of Bevacizumab in the Treatment of Radiation Necrosis in Children With Central Nervous System Tumors [NA]

View source ↗

Summary

Clinical trial on bevacizumab for radiation necrosis in children with central nervous system tumors has been terminated; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Tumors in Children
• Radiation Necrosis

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Radiation Necrosis | NA | Status: TERMINATED | Results posted: 2021-04-29